GENETICALLY DIRECTED HSD3B1 THERAPEUTICS FOR METASTATIC PROSTATE CANCER

$1,137,102FY2020Defense Health AgencyDOD

The Cleveland Clinic Foundation

Investigators

View source on USAspending →